Hospital for Special Surgery, New York clinical trial pipeline

6 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 4 with minor changes only.

1. Notable

   Belimumab and Rituximab Combination Therapy · Diffuse Cutaneous…Belimumab and Rituximab Combination Therapy · Diffuse Cutaneous Systemic Sclerosis

   Primary completion pushed from Jun 30, 2026 to Aug 30, 2027

   Also in this update: Enrollment closed, study ongoing; Study completion pushed from Jun 30, 2026 to Dec 30, 2027

   Hospital for Special Surgery, New York·Phase 2· NCT03844061· Registry history of NCT03844061 on ClinicalTrials.gov (opens the registry)

   Updated Oct 14, 2026

2. Notable

   PRP for Glenohumeral Osteoarthritis

   Primary completion pushed from Sep 1, 2026 to Jun 1, 2028

   Also in this update: Study completion pushed from Sep 1, 2026 to Jun 1, 2029

   Hospital for Special Surgery, New York·Phase 4· NCT05675527· Registry history of NCT05675527 on ClinicalTrials.gov (opens the registry)

   Updated Oct 9, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.